Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 208 articles:
HTML format
Text format



Single Articles


    July 2017
  1. YU FH, Huang KJ, Wang CT
    Correction for Yu et al., "C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain".
    J Virol. 2017;91.
    PubMed     Text format    


  2. WANG K, Tomaras GD, Jegaskanda S, Moody MA, et al
    Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate ADCC, and Protect Mice from Ocular Challenge with HSV-1
    J Virol. 2017 Jul 12. pii: JVI.00411-17. doi: 10.1128/JVI.00411.
    PubMed     Text format     Abstract available


  3. BOGERS WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, et al
    Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    J Virol. 2017 Jul 12. pii: JVI.00811-17. doi: 10.1128/JVI.00811.
    PubMed     Text format     Abstract available


  4. DESROSIERS RC
    Protection against HIV Acquisition in the RV144 Trial.
    J Virol. 2017 Jul 12. pii: JVI.00905-17. doi: 10.1128/JVI.00905.
    PubMed     Text format     Abstract available


  5. BAUER A, Podola L, Mann P, Missanga M, et al
    Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA prime - Modified Vaccinia Ankara (MVA) boost HIV-1 vaccine regimen.
    J Virol. 2017 Jul 12. pii: JVI.00730-17. doi: 10.1128/JVI.00730.
    PubMed     Text format     Abstract available


  6. MADHAVI V, Wines BD, Amin J, Emery S, et al
    HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV.
    J Virol. 2017 Jul 12. pii: JVI.00700-17. doi: 10.1128/JVI.00700.
    PubMed     Text format     Abstract available


  7. ANTHONY C, York T, Bekker V, Matten D, et al
    Co-operation between strain-specific and broadly neutralizing responses limited viral escape, and prolonged exposure of the broadly neutralizing epitope.
    J Virol. 2017 Jul 5. pii: JVI.00828-17. doi: 10.1128/JVI.00828.
    PubMed     Text format     Abstract available


  8. KE R, Cong ME, Li D, Garcia-Lerma G, et al
    On the death rate of abortively infected cells: estimation from simian/human immunodeficiency virus infection.
    J Virol. 2017 Jul 5. pii: JVI.00352-17. doi: 10.1128/JVI.00352.
    PubMed     Text format     Abstract available


  9. FELLINGER CH, Gardner MR, Bailey CC, Farzan M, et al
    SIVmac239, but not SIVmac316, binds and utilizes human CD4 more efficiently than rhesus CD4.
    J Virol. 2017 Jul 5. pii: JVI.00847-17. doi: 10.1128/JVI.00847.
    PubMed     Text format     Abstract available


  10. FUJINO M, Sato H, Okamura T, Uda A, et al
    Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    June 2017
  11. DING X, Zhang X, Chong H, Zhu Y, et al
    Enfuvirtide (T20)-based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implication for Viral Entry and Inhibition.
    J Virol. 2017 Jun 28. pii: JVI.00831-17. doi: 10.1128/JVI.00831.
    PubMed     Text format     Abstract available


  12. ARIF MS, Hunter J, Leda AR, Zukurov JPL, et al
    The Pace of Co-receptor Tropism Switch in HIV-1 Infected Individuals after Recent Infection.
    J Virol. 2017 Jun 28. pii: JVI.00793-17. doi: 10.1128/JVI.00793.
    PubMed     Text format     Abstract available


  13. NAIDOO VL, Mann JK, Noble C, Adland E, et al
    Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-driven Replication Capacity.
    J Virol. 2017 Jun 21. pii: JVI.00518-17. doi: 10.1128/JVI.00518.
    PubMed     Text format     Abstract available


  14. SHI Y, Kawana-Tachikawa A, Gao F, Qi J, et al
    Conserved Vdelta1 binding geometry in a setting of locus-disparate pHLA recognition by delta/alphabetaTCRs: insight into recognition of HIV peptides by TCR.
    J Virol. 2017 Jun 14. pii: JVI.00725-17. doi: 10.1128/JVI.00725.
    PubMed     Text format     Abstract available


  15. MADISON MK, Lawson DQ, Elliott J, Ozanturk AN, et al
    Allosteric HIV-1 Integrase Inhibitors Lead to Premature Degradation of the Viral RNA Genome and Integrase in Target Cells.
    J Virol. 2017 Jun 14. pii: JVI.00821-17. doi: 10.1128/JVI.00821.
    PubMed     Text format     Abstract available


  16. POWELL RLR, Totrov M, Itri V, Liu X, et al
    Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.
    J Virol. 2017 Jun 14. pii: JVI.00410-17. doi: 10.1128/JVI.00410.
    PubMed     Text format     Abstract available


  17. WAGNER GA, Landais E, Caballero G, Phung P, et al
    Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
    J Virol. 2017 Jun 14. pii: JVI.00475-17. doi: 10.1128/JVI.00475.
    PubMed     Text format     Abstract available


  18. MILLER SM, Miles B, Guo K, Folkvord J, et al
    Follicular regulatory T cells are highly permissive to R5-tropic HIV-1.
    J Virol. 2017 Jun 14. pii: JVI.00430-17. doi: 10.1128/JVI.00430.
    PubMed     Text format     Abstract available


  19. ALSAHAFI N, Richard J, Prevost J, Coutu M, et al
    Impaired downregulation of NKG2D ligands by Nef protein from elite controllers sensitizes HIV-1-infected cells to ADCC.
    J Virol. 2017 Jun 14. pii: JVI.00109-17. doi: 10.1128/JVI.00109.
    PubMed     Text format     Abstract available


  20. BALE S, Goebrecht G, Stano A, Wilson R, et al
    Covalent linkage of HIV-1 trimers to synthetic liposomes elicits improved B cell and antibody responses.
    J Virol. 2017 Jun 7. pii: JVI.00443-17. doi: 10.1128/JVI.00443.
    PubMed     Text format     Abstract available


  21. BALAMURUGAN A, Claiborne D, Ng HL, Yang OO, et al
    HIV-1 Epitope Variability Is Associated With T Cell Receptor Repertoire Instability and Breadth.
    J Virol. 2017 Jun 7. pii: JVI.00771-17. doi: 10.1128/JVI.00771.
    PubMed     Text format     Abstract available


  22. RUIZ-RIOL M, Berdnik D, Llano A, Mothe B, et al
    Identification of IL-27/IL-27RA as a critical immune axis for in vivo HIV control.
    J Virol. 2017 Jun 7. pii: JVI.00441-17. doi: 10.1128/JVI.00441.
    PubMed     Text format     Abstract available


  23. MAZZUCA P, Marsico S, Schulze K, Mitola S, et al
    Role of autophagy in the HIV-1 matrix protein p17-driven lymphangiogenesis.
    J Virol. 2017 Jun 7. pii: JVI.00801-17. doi: 10.1128/JVI.00801.
    PubMed     Text format     Abstract available


  24. MUJIB S, Liu J, Rahman AKMN, Schwartz JA, et al
    Comprehensive cross-clade characterization of antibody-mediated recognition, complement-mediated lysis and cell-mediated cytotoxicity of HIV-1 envelope specific antibodies towards the eradication of the HIV-1 reservoir.
    J Virol. 2017 Jun 7. pii: JVI.00634-17. doi: 10.1128/JVI.00634.
    PubMed     Text format     Abstract available


    May 2017
  25. SUGIMOTO C, Merino KM, Hasegawa A, Wang X, et al
    A Critical Role for Monocytes/Macrophages in the Rapid Progression to AIDS in Pediatric SIV-Infected Rhesus Macaques.
    J Virol. 2017 May 31. pii: JVI.00379-17. doi: 10.1128/JVI.00379.
    PubMed     Text format     Abstract available


  26. BOLDUC JF, Hany L, Barat C, Ouellet M, et al
    Epigenetic metabolite acetate inhibits class I/II histone deacetylases, promotes histone acetylation and increases HIV-1 integration in CD4+ T cells.
    J Virol. 2017 May 24. pii: JVI.01943-16. doi: 10.1128/JVI.01943.
    PubMed     Text format     Abstract available


  27. DILLEY KA, Nikolaitchik OA, Galli A, Burdick RC, et al
    Interactions Between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    J Virol. 2017 May 24. pii: JVI.02319-16. doi: 10.1128/JVI.02319.
    PubMed     Text format     Abstract available


  28. RINGE RP, Ozorowski G, Rantalainen K, Struwe WB, et al
    Reducing V3 antigenicity and immunogenicity on soluble, native-like HIV-1 Env SOSIP trimers.
    J Virol. 2017 May 24. pii: JVI.00677-17. doi: 10.1128/JVI.00677.
    PubMed     Text format     Abstract available


  29. LEE WS, Kristensen AB, Rasmussen TA, Tolstrup M, et al
    Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption.
    J Virol. 2017 May 24. pii: JVI.00603-17. doi: 10.1128/JVI.00603.
    PubMed     Text format     Abstract available


  30. JULG B, Pegu A, Abbink P, Liu J, et al
    Virological control by the CD4-binding site antibody N6 in SHIV-infected rhesus monkeys.
    J Virol. 2017 May 24. pii: JVI.00498-17. doi: 10.1128/JVI.00498.
    PubMed     Text format     Abstract available


  31. HU G, Liu J, Roux KH, Taylor KA, et al
    Structure of Simian Immunodeficiency Virus Envelope Spikes bound with CD4 and Monoclonal Antibody 36D5.
    J Virol. 2017 May 24. pii: JVI.00134-17. doi: 10.1128/JVI.00134.
    PubMed     Text format     Abstract available


  32. ZHAO M, Zheng ZZ, Chen M, Modjarrad K, et al
    Discovery of a Prefusion RSV F-Specific Monoclonal Antibody that Provides Greater in vivo Protection than the Murine Precursor of Palivizumab.
    J Virol. 2017 May 24. pii: JVI.00176-17. doi: 10.1128/JVI.00176.
    PubMed     Text format     Abstract available


  33. DECALF J, Desdouits M, Rodrigues V, Gobert FX, et al
    Sensing of HIV-1 entry triggers a type I interferon response in human primary macrophages.
    J Virol. 2017 May 10. pii: JVI.00147-17. doi: 10.1128/JVI.00147.
    PubMed     Text format     Abstract available


  34. JOHNSON J, Zhai Y, Salimi H, Espy N, et al
    Induction of a Tier-1-like Phenotype in Diverse Tier-2 Isolates by Agents that Guide HIV-1 Env to Perturbation-sensitive, Non-native States.
    J Virol. 2017 May 10. pii: JVI.00174-17. doi: 10.1128/JVI.00174.
    PubMed     Text format     Abstract available


  35. SHEN X, Bogers WM, Yates NL, Ferrari G, et al
    Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
    J Virol. 2017 May 10. pii: JVI.00401-17. doi: 10.1128/JVI.00401.
    PubMed     Text format     Abstract available


  36. BURANAPRADITKUN S, Pissani F, Teigler JE, Schultz BT, et al
    Preservation of peripheral T follicular helper cell function in HIV controllers.
    J Virol. 2017 May 3. pii: JVI.00497-17. doi: 10.1128/JVI.00497.
    PubMed     Text format     Abstract available


    April 2017
  37. MARTIN JL, Mendonca L, Angert I, Mueller JD, et al
    Disparate contributions of human retrovirus capsid subdomains to Gag-Gag oligomerization, virus morphology and particle biogenesis.
    J Virol. 2017 Apr 26. pii: JVI.00298-17. doi: 10.1128/JVI.00298.
    PubMed     Text format     Abstract available


  38. STANO A, Leaman DP, Kim AS, Zhang L, et al
    Dense array of spikes on HIV-1 virion particles.
    J Virol. 2017 Apr 26. pii: JVI.00415-17. doi: 10.1128/JVI.00415.
    PubMed     Text format     Abstract available


  39. BRILLEN AL, Walotka L, Hillebrand F, Muller L, et al
    Analysis of competing HIV-1 splice donor sites uncovers a tight cluster of splicing regulatory elements within exon 2/2b.
    J Virol. 2017 Apr 26. pii: JVI.00389-17. doi: 10.1128/JVI.00389.
    PubMed     Text format     Abstract available


  40. MILLER CM, Akiyama H, Agosto LM, Emery A, et al
    Virion associated Vpr alleviates a post-integration block to HIV-1 infection of dendritic cells.
    J Virol. 2017 Apr 19. pii: JVI.00051-17. doi: 10.1128/JVI.00051.
    PubMed     Text format     Abstract available


  41. KIGUOYA MW, Mann JK, Chopera D, Gounder K, et al
    Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity are Consistent with Inter-Subtype Differences in HIV-1 Disease Progression.
    J Virol. 2017 Apr 19. pii: JVI.00253-17. doi: 10.1128/JVI.00253.
    PubMed     Text format     Abstract available


  42. DI PILATO M, Mejias-Perez E, Sorzano COS, Esteban M, et al
    Distinct roles of vaccinia virus NF-kB inhibitor proteins A52, B15 and K7 in the immune response.
    J Virol. 2017 Apr 19. pii: JVI.00575-17. doi: 10.1128/JVI.00575.
    PubMed     Text format     Abstract available


  43. REEVES DB, Peterson CW, Kiem HP, Schiffer JT, et al
    Autologous stem-cell transplantation disrupts adaptive immune responses during rebound SHIV viremia.
    J Virol. 2017 Apr 12. pii: JVI.00095-17. doi: 10.1128/JVI.00095.
    PubMed     Text format     Abstract available


  44. RANKOVIC S, Varadarajan J, Ramalho R, Aiken C, et al
    Reverse transcription mechanically initiates HIV-1 capsid disassembly.
    J Virol. 2017 Apr 5. pii: JVI.00289-17. doi: 10.1128/JVI.00289.
    PubMed     Text format     Abstract available


  45. RINGE RP, Ozorowski G, Yasmeen A, Cupo A, et al
    Improving the expression and purification of soluble, recombinant native-like HIV-1 envelope glycoprotein trimers by targeted sequence changes.
    J Virol. 2017 Apr 5. pii: JVI.00264-17. doi: 10.1128/JVI.00264.
    PubMed     Text format     Abstract available


  46. YI F, Guo J, Dabbagh D, Spear M, et al
    Discovery of Novel Small Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.
    J Virol. 2017 Apr 5. pii: JVI.02418-16. doi: 10.1128/JVI.02418.
    PubMed     Text format     Abstract available


  47. BAIG TT, Feng Y, Chelico L
    Correction for Baig et al., Determinants of Efficient Degradation of APOBEC3 Restriction Factors by HIV-1 Vif.
    J Virol. 2017;91.
    PubMed     Text format    


    March 2017
  48. CHONG H, Xue J, Xiong S, Cong Z, et al
    A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent in vitro, ex vivo and in vivo Antiviral Activity.
    J Virol. 2017 Mar 29. pii: JVI.00288-17. doi: 10.1128/JVI.00288.
    PubMed     Text format     Abstract available


  49. PETERLIN BM, Liu P, Wang X, Cary D, et al
    Hili inhibits HIV replication in activated T cells.
    J Virol. 2017 Mar 22. pii: JVI.00237-17. doi: 10.1128/JVI.00237.
    PubMed     Text format     Abstract available


  50. RICHARD J, Prevost J, von Bredow B, Ding S, et al
    BST-2 Expression Modulates Small CD4 Mimetic Sensitization of HIV-1-infected cells to ADCC.
    J Virol. 2017 Mar 22. pii: JVI.00219-17. doi: 10.1128/JVI.00219.
    PubMed     Text format     Abstract available


  51. YOSHIKAWA R, Takeuchi JS, Yamada E, Nakano Y, et al
    Feline immunodeficiency virus evolutionarily acquires two proteins, Vif and protease, capable of antagonizing feline APOBEC3.
    J Virol. 2017 Mar 22. pii: JVI.00250-17. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available


  52. CUMMINS NW, Sainski-Nguyen AM, Natesampillai S, Aboulnasr F, et al
    Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition.
    J Virol. 2017 Mar 22. pii: JVI.00012-17. doi: 10.1128/JVI.00012.
    PubMed     Text format     Abstract available


  53. GAO J, Hay TJ, Banfield BW
    The Product of the Herpes Simplex Virus Type 2 UL16 Gene is Critical for the Egress of Capsids from the Nuclei of Infected Cells.
    J Virol. 2017 Mar 8. pii: JVI.00350-17. doi: 10.1128/JVI.00350.
    PubMed     Text format     Abstract available


  54. CHUANG GY, Geng H, Pancera M, Xu K, et al
    Structure-Based Design of a Soluble Prefusion-Closed HIV-1-Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
    J Virol. 2017 Mar 8. pii: JVI.02268-16. doi: 10.1128/JVI.02268.
    PubMed     Text format     Abstract available


  55. ZHANG X, Zhou T, Yang J, Lin Y, et al
    Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.
    J Virol. 2017 Mar 8. pii: JVI.00137-17. doi: 10.1128/JVI.00137.
    PubMed     Text format     Abstract available


  56. MARNO KM, O'Sullivan E, Jones CE, Diaz-Delfin J, et al
    RNA-associated Early-stage Anti-viral Factor (REAF) is a major component of LV2 restriction.
    J Virol. 2017 Mar 8. pii: JVI.01228-16. doi: 10.1128/JVI.01228.
    PubMed     Text format     Abstract available


  57. HUANG J, Zhu L, Qiu C, Xu X, et al
    MiR-126-5p enhances the inflammatory responses of monocytes to LPS stimulation by suppressing CYLD in chronic HIV-1 infection.
    J Virol. 2017 Mar 1. pii: JVI.02048-16. doi: 10.1128/JVI.02048.
    PubMed     Text format     Abstract available


  58. LIU Y, Pan J, Cai Y, Grigorieff N, et al
    Conformational states of a soluble, uncleaved HIV-1 envelope trimer.
    J Virol. 2017 Mar 1. pii: JVI.00175-17. doi: 10.1128/JVI.00175.
    PubMed     Text format     Abstract available


  59. OPAZO T, Garces A, Tapia D, Barraza F, et al
    Functional evidence of the involvement of the dynein light chain DYNLRB2 in murine leukemia virus infection.
    J Virol. 2017 Mar 1. pii: JVI.00129-17. doi: 10.1128/JVI.00129.
    PubMed     Text format     Abstract available


  60. SMITH SA, Derdeyn CA
    New connections: Cell to cell HIV-1 transmission, resistance to broadly neutralizing antibodies, and an envelope sorting motif.
    J Virol. 2017 Mar 1. pii: JVI.00149-17. doi: 10.1128/JVI.00149.
    PubMed     Text format     Abstract available


  61. STULTZ RD, Cenker JJ, McDonald D
    Imaging HIV-1 Genomic DNA from Entry through Productive Infection.
    J Virol. 2017 Mar 1. pii: JVI.00034-17. doi: 10.1128/JVI.00034.
    PubMed     Text format     Abstract available


  62. KENNEDY EM, Courtney DG, Tsai K, Cullen BR, et al
    Viral Epitranscriptomics.
    J Virol. 2017 Mar 1. pii: JVI.02263-16. doi: 10.1128/JVI.02263.
    PubMed     Text format     Abstract available


  63. YU FH, Huang KJ, Wang CT
    C-terminal HIV-1 transframe p6* tetra-peptide blocks enhanced Gag cleavage incurred by leucine zipper replacement of a deleted p6* domain.
    J Virol. 2017 Mar 1. pii: JVI.00103-17. doi: 10.1128/JVI.00103.
    PubMed     Text format     Abstract available


    February 2017
  64. WANG W, Zhou J, Halambage UD, Jurado KA, et al
    Inhibition of HIV-1 Maturation via Small Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    J Virol. 2017 Feb 15. pii: JVI.02155-16. doi: 10.1128/JVI.02155.
    PubMed     Text format     Abstract available


  65. ZHENG X, Wang X, Tu F, Wang Q, et al
    TRIM25 Is Required for the Antiviral Activity of Zinc-finger Antiviral Protein (ZAP).
    J Virol. 2017 Feb 15. pii: JVI.00088-17. doi: 10.1128/JVI.00088.
    PubMed     Text format     Abstract available


  66. WANG H, Guo H, Su J, Rui Y, et al
    Inhibition of Vpx-mediated SAMHD1 and Vpr-mediated HLTF degradation by selective disruption of viral CRL4 (DCAF1) E3 ubiquitin ligase assembly.
    J Virol. 2017 Feb 15. pii: JVI.00225-17. doi: 10.1128/JVI.00225.
    PubMed     Text format     Abstract available


  67. MARTINEZ DR, Vandergrift N, Douglas AO, McGuire E, et al
    Maternal binding and neutralizing IgG responses targeting the C terminal region of the V3 loop are predictive of reduced peripartum HIV-1 transmission risk.
    J Virol. 2017 Feb 15. pii: JVI.02422-16. doi: 10.1128/JVI.02422.
    PubMed     Text format     Abstract available


  68. PETRAVIC J, Rasmussen TA, Lewin SR, Kent SJ, et al
    Relationship between measures of HIV reactivation and the decline of latent reservoir under latency-reversing agents.
    J Virol. 2017 Feb 15. pii: JVI.02092-16. doi: 10.1128/JVI.02092.
    PubMed     Text format     Abstract available


  69. GO EP, Ding H, Zhang S, Ringe RP, et al
    A glycosylation benchmark profile for HIV-1 envelope glycoprotein production based on eleven Env trimers.
    J Virol. 2017 Feb 15. pii: JVI.02428-16. doi: 10.1128/JVI.02428.
    PubMed     Text format     Abstract available


  70. QUAN Y, Xu H, Han Y, Mesplede T, et al
    JAK-STAT Signaling Pathways and Inhibitors Affect Reversion of Envelope Mutated HIV-1.
    J Virol. 2017 Feb 15. pii: JVI.00075-17. doi: 10.1128/JVI.00075.
    PubMed     Text format     Abstract available


  71. ZURAWSKI G, Shen X, Zurawski S, Tomaras GD, et al
    Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
    J Virol. 2017 Feb 15. pii: JVI.01596-16. doi: 10.1128/JVI.01596.
    PubMed     Text format     Abstract available


  72. GARCIA-ARRIAZA J, Perdiguero B, Heeney JL, Seaman MS, et al
    HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell i
    J Virol. 2017 Feb 8. pii: JVI.02182-16. doi: 10.1128/JVI.02182.
    PubMed     Text format     Abstract available


  73. TSAI A, Irrinki A, Kaur J, Cihlar T, et al
    Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    J Virol. 2017 Feb 8. pii: JVI.02166-16. doi: 10.1128/JVI.02166.
    PubMed     Text format     Abstract available


  74. YUE FY, Cohen JC, Ho M, Rahman AK, et al
    HIV-specific granzyme B, but not interferon-gamma secreting T Cells are associated with reduced viral reservoirs in early HIV infection.
    J Virol. 2017 Feb 8. pii: JVI.02233-16. doi: 10.1128/JVI.02233.
    PubMed     Text format     Abstract available


  75. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    Correction for Lund et al., HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.
    J Virol. 2017;91.
    PubMed     Text format    


  76. NASAR F, Matassov D, Seymour RL, Latham T, et al
    Recombinant Isfahan virus and vesicular stomatitis virus vaccine vectors provide durable, multivalent, single dose protection against lethal alphavirus challenge.
    J Virol. 2017 Feb 1. pii: JVI.01729-16. doi: 10.1128/JVI.01729.
    PubMed     Text format     Abstract available


  77. LI H, Zony C, Chen P, Chen BK, et al
    Reduced potency and incomplete neutralization of broadly neutralizing antibodies against cell-to-cell transmission of HIV-1 with transmitted founder Envs.
    J Virol. 2017 Feb 1. pii: JVI.02425-16. doi: 10.1128/JVI.02425.
    PubMed     Text format     Abstract available


  78. SUGDEN SM, Pham TN, Cohen EA
    HIV-1 Vpu downmodulates ICAM-1 expression resulting in decreased killing of infected CD4+ T cells by NK cells.
    J Virol. 2017 Feb 1. pii: JVI.02442-16. doi: 10.1128/JVI.02442.
    PubMed     Text format     Abstract available


  79. SELHORST P, Combrinck C, Ndabambi N, Ismail SD, et al
    REPLICATION CAPACITY OF VIRUSES FROM ACUTE INFECTION DRIVES HIV-1 DISEASE PROGRESSION.
    J Virol. 2017 Feb 1. pii: JVI.01806-16. doi: 10.1128/JVI.01806.
    PubMed     Text format     Abstract available


  80. CALONGE E, Bermejo M, Diez-Fuertes F, Mangeot I, et al
    Different Expression of Interferon Stimulated Genes in Response to HIV-1 Infection in Dendritic Cells According to Their Maturation State.
    J Virol. 2017 Feb 1. pii: JVI.01379-16. doi: 10.1128/JVI.01379.
    PubMed     Text format     Abstract available


    January 2017
  81. COLOMER-LLUCH M, Serra-Moreno R
    BCA2/RABRING7 Interferes with HIV-1 Proviral Transcription by Enhancing the SUMOylation of IkappaBalpha.
    J Virol. 2017 Jan 25. pii: JVI.02098-16. doi: 10.1128/JVI.02098.
    PubMed     Text format     Abstract available


  82. BRUEL T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, et al
    Lack of ADCC breadth of human non-neutralizing anti-HIV-1 antibodies.
    J Virol. 2017 Jan 25. pii: JVI.02440-16. doi: 10.1128/JVI.02440.
    PubMed     Text format     Abstract available


  83. ZHENG W, Ling L, Li Z, Wang H, et al
    Conserved interaction of lentiviral Vif molecules with HIV-1 Gag and differential effects of species-specific Vif on virus production.
    J Virol. 2017 Jan 25. pii: JVI.00064-17. doi: 10.1128/JVI.00064.
    PubMed     Text format     Abstract available


  84. WINANS S, Larue RC, Abraham CM, Shkriabai N, et al
    The FACT complex promotes avian leukosis virus DNA integration.
    J Virol. 2017 Jan 25. pii: JVI.00082-17. doi: 10.1128/JVI.00082.
    PubMed     Text format     Abstract available


  85. MUSICH T, Li L, Liu L, Zolla-Pazner S, et al
    Monoclonal Antibodies to V2, V3, the CD4-binding site and gp41 HIV-1 Mediate Phagocytosis in a Dose-dependent Manner.
    J Virol. 2017 Jan 25. pii: JVI.02325-16. doi: 10.1128/JVI.02325.
    PubMed     Text format     Abstract available


  86. PREVOST J, Zoubchenok D, Richard J, Veillette M, et al
    Influence of the Envelope Gp120 Phe 43 Cavity on HIV-1 Sensitivity to ADCC Responses.
    J Virol. 2017 Jan 18. pii: JVI.02452-16. doi: 10.1128/JVI.02452.
    PubMed     Text format     Abstract available


  87. WANG Y, Pan Q, Ding S, Wang Z, et al
    The V3-loop of HIV-1 Env determines viral susceptibility to IFITM3 impairment of viral infectivity.
    J Virol. 2017 Jan 18. pii: JVI.02441-16. doi: 10.1128/JVI.02441.
    PubMed     Text format     Abstract available


  88. RAHMBERG AR, Rajakumar PA, Billingsley JM, Johnson RP, et al
    Dynamic modulation of expression of lentiviral restriction factors in primary CD4+ T cells following SIV infection.
    J Virol. 2017 Jan 18. pii: JVI.02189-16. doi: 10.1128/JVI.02189.
    PubMed     Text format     Abstract available


  89. RIHN SJ, Foster TL, Busnadiego I, Aziz MA, et al
    The Envelope Gene of Transmitted HIV-1 Resists a Late IFNgamma-Induced Block.
    J Virol. 2017 Jan 18. pii: JVI.02254-16. doi: 10.1128/JVI.02254.
    PubMed     Text format     Abstract available


  90. LAHER F, Ranasinghe S, Porichis F, Mewalal N, et al
    HIV controllers exhibit enhanced frequencies of MHC class II tetramer+ Gag-specific CD4+ T cells in chronic clade C HIV-1 infection.
    J Virol. 2017 Jan 11. pii: JVI.02477-16. doi: 10.1128/JVI.02477.
    PubMed     Text format     Abstract available


  91. EMERY A, Zhou S, Pollom E, Swanstrom R, et al
    Characterizing HIV-1 Splicing Using Next Generation Sequencing.
    J Virol. 2017 Jan 11. pii: JVI.02515-16. doi: 10.1128/JVI.02515.
    PubMed     Text format     Abstract available


  92. FLERIN NC, Chen H, Glover TD, Lamothe PA, et al
    TCR Clonotype-specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T Cell Clones is Not Mediated by TCR Alone.
    J Virol. 2017 Jan 11. pii: JVI.02412-16. doi: 10.1128/JVI.02412.
    PubMed     Text format     Abstract available


  93. RODGERS MA, Wilkerson E, Vallari A, McArthur C, et al
    Sensitive next generation sequencing method reveals deep genetic diversity of HIV-1 in the Democratic Republic of the Congo.
    J Virol. 2017 Jan 11. pii: JVI.01841-16. doi: 10.1128/JVI.01841.
    PubMed     Text format     Abstract available


  94. PEREIRA BITTENCOURT PASSAES C, Bruel T, Decalf J, David A, et al
    Ultrasensitive HIV-1 p24 detects single infected cells and differences in reservoir induction by latency-reversal agents.
    J Virol. 2017 Jan 11. pii: JVI.02296-16. doi: 10.1128/JVI.02296.
    PubMed     Text format     Abstract available


  95. MACK K, Starz K, Sauter D, Langer S, et al
    Efficient Vpu-mediated tetherin antagonism by an HIV-1 group O strain.
    J Virol. 2017 Jan 11. pii: JVI.02177-16. doi: 10.1128/JVI.02177.
    PubMed     Text format     Abstract available


  96. HO CK, Raghwani J, Koekkoek S, Liang RH, et al
    Characterization of HCV envelope diversification from acute to chronic infection using SMRT sequencing within a sexually-transmitted hepatitis C virus cluster.
    J Virol. 2017 Jan 11. pii: JVI.02262-16. doi: 10.1128/JVI.02262.
    PubMed     Text format     Abstract available


  97. SCHMIDT F, Liegeois F, Greenwood EJ, LeBreton M, et al
    Phyloepidemiological analysis reveals that viral divergence led to the paucity of SIVmus/gsn/mon infections in wild populations.
    J Virol. 2017 Jan 11. pii: JVI.01884-16. doi: 10.1128/JVI.01884.
    PubMed     Text format     Abstract available


  98. DONAHUE DA, Porrot F, Couespel N, Schwartz O, et al
    SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A.
    J Virol. 2017 Jan 11. pii: JVI.02303-16. doi: 10.1128/JVI.02303.
    PubMed     Text format     Abstract available


  99. JACOBS ES, Keating SM, Abdel-Mohsen M, Gibb SL, et al
    Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication in vitro and Modulate HIV Restriction Factor Expression.
    J Virol. 2017 Jan 4. pii: JVI.02051-16. doi: 10.1128/JVI.02051.
    PubMed     Text format     Abstract available


  100. BECKER JT, Sherer NM
    Subcellular localization of HIV-1 gag-pol mRNAs regulates sites of virion assembly.
    J Virol. 2017 Jan 4. pii: JVI.02315-16. doi: 10.1128/JVI.02315.
    PubMed     Text format     Abstract available


    December 2016
  101. OOMS M, Letko M, Simon V
    The structural interface between HIV-1 Vif and human APOBEC3H.
    J Virol. 2016 Dec 28. pii: JVI.02289-16. doi: 10.1128/JVI.02289.
    PubMed     Text format     Abstract available


  102. PACHECO B, Alsahafi N, Debbeche O, Prevost J, et al
    Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-directed Inhibitors.
    J Virol. 2016 Dec 21. pii: JVI.02219-16. doi: 10.1128/JVI.02219.
    PubMed     Text format     Abstract available


  103. LEE J, Malmberg JL, Wood BA, Hladky S, et al
    Feline immunodeficiency virus cross-species transmission: Implications for emergence of new lentiviral infections.
    J Virol. 2016 Dec 21. pii: JVI.02134-16. doi: 10.1128/JVI.02134.
    PubMed     Text format     Abstract available


  104. BOLDUC JF, Ouellet M, Hany L, Tremblay MJ, et al
    TLR2 ligation enhances HIV-1 replication in activated CCR6+CD4+ T cells by increasing virus entry and establishing a more permissive environment to infection.
    J Virol. 2016 Dec 7. pii: JVI.01402.
    PubMed     Text format     Abstract available


  105. ROCHAT MA, Schlaepfer E, Speck RF
    Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    J Virol. 2016 Dec 7. pii: JVI.02084.
    PubMed     Text format     Abstract available


  106. ZOUBCHENOK D, Veillette M, Prevost J, Sanders-Buell E, et al
    Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
    J Virol. 2016 Dec 7. pii: JVI.02151.
    PubMed     Text format     Abstract available


  107. DIETRICH MH, Ogden KM, Katen SP, Reiss K, et al
    Structural Insights into Reovirus sigma1 Interactions with Two Neutralizing Antibodies.
    J Virol. 2016 Dec 7. pii: JVI.01621.
    PubMed     Text format     Abstract available


  108. SHAW JM, Miller-Novak LK, Mohanram V, McKinnon K, et al
    Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, SIV-Infected Rhesus Macaques with Low and High Viremia.
    J Virol. 2016 Dec 7. pii: JVI.01727.
    PubMed     Text format     Abstract available


  109. BEITARI S, Ding S, Pan Q, Finzi A, et al
    The effect of HIV-1 Env on SERINC5 antagonism.
    J Virol. 2016 Dec 7. pii: JVI.02214.
    PubMed     Text format     Abstract available


  110. KASTURI SP, Kozlowski PA, Nakaya HI, Burger MC, et al
    Adjuvanting an SIV vaccine with TLR ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques.
    J Virol. 2016 Dec 7. pii: JVI.01844.
    PubMed     Text format     Abstract available


    November 2016
  111. WETZEL KS, Yi Y, Elliott ST, Romero D, et al
    CXCR6-mediated SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    J Virol. 2016 Nov 30. pii: JVI.01626.
    PubMed     Text format     Abstract available


  112. WANG L, Wang Y, Zhao J, Ren J, et al
    LUBAC modulates LMP1 activation of NFkappaB and IRF7.
    J Virol. 2016 Nov 30. pii: JVI.01138.
    PubMed     Text format     Abstract available


  113. MURAKOSHI H, Koyanagi M, Chikata T, Rahman MA, et al
    Accumulation of Pol mutations selected by HLA-B*52:01-C*12:02 protective haplotype-restricted CTLs causes low plasma viral load due to low viral fitness of mutant viruses.
    J Virol. 2016 Nov 30. pii: JVI.02082.
    PubMed     Text format     Abstract available


  114. YE C, Wang W, Cheng L, Li G, et al
    Glycosyl-phosphatidylinositol (GPI)-anchored anti-HIV scFv efficiently protect CD4 T cells from HIV-1 infection and deletion in hu-PBL mice.
    J Virol. 2016 Nov 23. pii: JVI.01389.
    PubMed     Text format     Abstract available


  115. WANG Y, Mao L, Kankanala J, Wang Z, et al
    Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage.
    J Virol. 2016 Nov 23. pii: JVI.02152.
    PubMed     Text format     Abstract available


  116. ARA A, Love RP, Follack TB, Ahmed KA, et al
    Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G.
    J Virol. 2016 Nov 23. pii: JVI.02230.
    PubMed     Text format     Abstract available


  117. MADANI N, Princiotto AM, Zhao C, Jahanbakhshsefidi F, et al
    Activation and Inactivation of Primary Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    J Virol. 2016 Nov 23. pii: JVI.01880.
    PubMed     Text format     Abstract available


  118. BEHRENS RT, Aligeti M, Pocock GM, Higgins CA, et al
    NES masking regulates HIV-1 Rev trafficking and viral RNA nuclear export.
    J Virol. 2016 Nov 16. pii: JVI.02107.
    PubMed     Text format     Abstract available


  119. LIU X, Happel C, Ziegelbauer JM
    KSHV microRNAs Target GADD45B to Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    J Virol. 2016 Nov 16. pii: JVI.02045.
    PubMed     Text format     Abstract available


  120. PINCUS SH, Song K, Maresh GA, Hamer DH, et al
    Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
    J Virol. 2016 Nov 16. pii: JVI.01955.
    PubMed     Text format     Abstract available


  121. WANG L, Eng ET, Law K, Gordon RE, et al
    Visualization of HIV T cell virological synapses and virus-containing compartments by 3D correlative light and electron microscopy.
    J Virol. 2016 Nov 9. pii: JVI.01605.
    PubMed     Text format     Abstract available


  122. BEHRENS AJ, Harvey DJ, Milne E, Cupo A, et al
    Molecular architecture of the cleavage-dependent mannose patch on a soluble HIV-1 envelope glycoprotein trimer.
    J Virol. 2016 Nov 2. pii: JVI.01894.
    PubMed     Text format     Abstract available


    October 2016
  123. WANG GZ, Goff SP
    Transcriptional Silencing of Moloney Murine Leukemia Virus in Human Embryonic Carcinoma Cells.
    J Virol. 2016 Oct 26. pii: JVI.02075.
    PubMed     Text format     Abstract available


  124. TAKAHATA T, Takeda E, Tobiume M, Tokunaga K, et al
    Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) to Facilitate the IN Assembly and Non-enzymatic Function Through the IN Precursor Form with Reverse Transcriptase.
    J Virol. 2016 Oct 19. pii: JVI.02003.
    PubMed     Text format     Abstract available


  125. XIONG S, Borrego P, Ding X, Zhu Y, et al
    A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activities against HIV-1, HIV-2 and Simian Immunodeficiency Virus.
    J Virol. 2016 Oct 19. pii: JVI.01839.
    PubMed     Text format     Abstract available


  126. LI C, Wang HB, Kuang WD, Ren XX, et al
    Naf1 regulates HIV-1 latency by suppressing viral promoter-driven gene expression in primary CD4+ T cells.
    J Virol. 2016 Oct 19. pii: JVI.01830.
    PubMed     Text format     Abstract available


  127. CHEESEMAN HM, Olejniczak NJ, Rogers PM, Evans AB, et al
    Broadly Neutralising Antibodies Display Superior Potential Over Non-Neutralising Antibodies in Preventing HIV-1 infection of Mucosal Tissue.
    J Virol. 2016 Oct 19. pii: JVI.01762.
    PubMed     Text format     Abstract available


  128. SU S, Zhu Y, Ye S, Qi Q, et al
    Creating an artificial tail-anchor as a novel strategy to enhance the potency of peptide-based HIV fusion inhibitors.
    J Virol. 2016 Oct 19. pii: JVI.01445.
    PubMed     Text format     Abstract available


  129. WAKEMAN BS, Izumiya Y, Speck SH
    Identification of novel KSHV Orf50 transcripts: discovery of new RTA isoforms with variable transactivation potential.
    J Virol. 2016 Oct 19. pii: JVI.01434.
    PubMed     Text format     Abstract available


  130. PINCUS SH, Song K, Maresh GA, Frank A, et al
    Design and In Vivo Characterization of Immunoconjugates Targeting HIV gp160.
    J Virol. 2016 Oct 19. pii: JVI.01360.
    PubMed     Text format     Abstract available


  131. COSS KP, Vasiljevic S, Pritchard LK, Krumm SA, et al
    HIV-1 glycan density drives the persistence of the mannose patch within an infected individual.
    J Virol. 2016 Oct 5. pii: JVI.01542.
    PubMed     Text format     Abstract available


  132. JIANG X, Totrov M, Li W, Sampson JM, et al
    Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    J Virol. 2016 Oct 5. pii: JVI.01409.
    PubMed     Text format     Abstract available


  133. LI S, Folkvord JM, Rakasz EG, Abdelaal HM, et al
    SIV-producing cells in follicles are partially suppressed by CD8+ cells in vivo.
    J Virol. 2016 Oct 5. pii: JVI.01332.
    PubMed     Text format     Abstract available


    September 2016
  134. WU F, Kirmaier A, White E, Ourmanov I, et al
    TRIM5alpha Resistance Escape Mutations in Capsid are Transferable Between Simian Immunodeficiency Virus Strains.
    J Virol. 2016 Sep 28. pii: JVI.01620.
    PubMed     Text format     Abstract available


  135. CHEN CY, Shingai M, Welbourn S, Martin MA, et al
    Antagonism of BST-2/tetherin is a conserved function of the Env glycoprotein of primary HIV-2 isolates.
    J Virol. 2016 Sep 28. pii: JVI.01451.
    PubMed     Text format     Abstract available


  136. TRAUTZ B, Pierini V, Wombacher R, Stolp B, et al
    Antagonism of the SERINC5 Particle Infectivity Restriction by HIV-1 Nef Involves Counteraction of Virion-associated Pools of the Restriction Factor.
    J Virol. 2016 Sep 28. pii: JVI.01246.
    PubMed     Text format     Abstract available


  137. LACOMBE B, Morel M, Margottin-Goguet F, Ramirez BC, et al
    Specific inhibition of HIV infection by spironolactone in T cells.
    J Virol. 2016 Sep 28. pii: JVI.01722.
    PubMed     Text format     Abstract available


  138. EGGINK D, de Taeye SW, Bontjer I, Klasse PJ, et al
    HIV-1 escape from a peptidic anchor inhibitor by envelope glycoprotein spike stabilization.
    J Virol. 2016 Sep 21. pii: JVI.01616.
    PubMed     Text format     Abstract available


  139. LONGO NS, Sutton MS, Shiakolas AR, Guenaga J, et al
    Multiple antibody lineages in one donor target the glycan-V3 supersite of the HIV-1 envelope glycoprotein and display a preference for quaternary binding.
    J Virol. 2016 Sep 21. pii: JVI.01012.
    PubMed     Text format     Abstract available


  140. ARIAS JF, Colomer-Lluch M, von Bredow B, Greene JM, et al
    Tetherin Antagonism by HIV-1 Group M Nef Proteins.
    J Virol. 2016 Sep 21. pii: JVI.01465.
    PubMed     Text format     Abstract available


  141. LIU L, Wang W, Matz J, Ye C, et al
    Glycosyl Phosphatidylinositol-Anchored Variable Region of Llama Heavy Chain Only Antibody JM4 Efficiently Blocks Both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    J Virol. 2016 Sep 21. pii: JVI.01559.
    PubMed     Text format     Abstract available


  142. DENG J, Mitsuki YY, Shen G, Ray J, et al
    HIV envelope gp120 alters T-cell receptor mobilization in the immunological synapse of uninfected CD4 T cells and augments the T cell activation.
    J Virol. 2016 Sep 14. pii: JVI.01532.
    PubMed     Text format     Abstract available


  143. GU Q, Zhang Z, Ortiz LC, Franco AC, et al
    FIV Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
    J Virol. 2016 Sep 14. pii: JVI.01593.
    PubMed     Text format     Abstract available


  144. PINZONE MR, Graf E, Lynch L, McLaughlin B, et al
    Monitoring integration over time supports a role for CTL and ongoing replication as determinants of reservoir size.
    J Virol. 2016 Sep 14. pii: JVI.00242.
    PubMed     Text format     Abstract available


  145. ZOLLA-PAZNER S, Powell R, Yahyaei S, Williams C, et al
    RATIONALLY-DESIGNED VACCINES TARGETING THE V2 REGION OF HIV-1 gp120 INDUCE A FOCUSED, CROSS CLADE-REACTIVE, BIOLOGICALLY FUNCTIONAL ANTIBODY RESPONSE.
    J Virol. 2016 Sep 14. pii: JVI.01403.
    PubMed     Text format     Abstract available


  146. COSTA M, Pollara J, Edwards RW, Seaman M, et al
    Fc receptor mediated activities by Env-specific human mAbs generated from volunteers receiving the DNA prime-protein boost HIV vaccine DP6-001.
    J Virol. 2016 Sep 14. pii: JVI.01458.
    PubMed     Text format     Abstract available


  147. PRENTICE HA, Lu H, Price MA, Kamali A, et al
    Dynamics and Correlates of CD8 T-cell Counts in Africans with Primary Human Immunodeficient Virus Type I (HIV-1) Infection.
    J Virol. 2016 Sep 14. pii: JVI.01467.
    PubMed     Text format     Abstract available


  148. KEATING SM, Heitman JW, Wu S, Deng X, et al
    Magnitude and quality of cytokine and chemokine storm during acute infection distinguish non-progressive and progressive simian immunodeficiency virus infections of nonhuman primates.
    J Virol. 2016 Sep 14. pii: JVI.01061.
    PubMed     Text format     Abstract available


    August 2016
  149. BEGO MG, Cong L, Mack K, Kirchhoff F, et al
    Differential Control of BST2 restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists encoded by HIV-1 Group M and O Strains.
    J Virol. 2016 Aug 31. pii: JVI.01131.
    PubMed     Text format     Abstract available


  150. WIBMER CK, Gorman J, Anthony CS, Mkhize NN, et al
    Structure of an N276-dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole adjacent to the CD4 Binding Site.
    J Virol. 2016 Aug 31. pii: JVI.01357.
    PubMed     Text format     Abstract available


  151. ZHANG Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, et al
    Vif Proteins from Diverse HIV/SIV Lineages have Distinct Binding Sites in A3C.
    J Virol. 2016 Aug 31. pii: JVI.01497.
    PubMed     Text format     Abstract available


  152. EBERHARDT MK, Deshpande A, Fike J, Short R, et al
    Exploitation of IL-10 Signaling Pathways: The Alternate Roles of Viral and Cellular IL-10 in Rhesus Cytomegalovirus Infection.
    J Virol. 2016 Aug 24. pii: JVI.00635.
    PubMed     Text format     Abstract available


  153. LA PORTE A, Cano J, Wu X, Mitra D, et al
    An essential role of INI1/hSNF5 chromatin remodeling protein in HIV-1 post-transcriptional events and Gag/GagPol stability.
    J Virol. 2016 Aug 24. pii: JVI.00323.
    PubMed     Text format     Abstract available


  154. AYALA VI, Trivett MT, Barsov EV, Jain S, et al
    Adoptive Transfer of Engineered Rhesus SIV-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques.
    J Virol. 2016 Aug 24. pii: JVI.01522.
    PubMed     Text format     Abstract available


  155. LUND JM, Broliden K, Pyra MN, Thomas KK, et al
    HIV-1-neutralizing IgA is detected in genital secretions of highly HIV-1 exposed seronegative women on oral pre-exposure prophylaxis.
    J Virol. 2016 Aug 24. pii: JVI.01482.
    PubMed     Text format     Abstract available


  156. BARRETO-DE-SOUZA V, Arakelyan A, Zicari S, Margolis L, et al
    Monocytes but not lymphocytes carrying HIV-1 on their surface transmit infection to human tissue ex vivo.
    J Virol. 2016 Aug 24. pii: JVI.00742.
    PubMed     Text format     Abstract available


  157. STARLING S, Jolly C
    LFA-1 engagement triggers T cell polarization at the HIV-1 virological synapse.
    J Virol. 2016 Aug 24. pii: JVI.01152.
    PubMed     Text format     Abstract available


  158. LIU B, Zou F, Lu L, Chen C, et al
    CAR-T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate the Reactivated Virus-latently-infected CD4+ T-lymphocytes Isolated from HIV-1-infected Individuals Receiving Suppressive cART.
    J Virol. 2016 Aug 17. pii: JVI.00852.
    PubMed     Text format     Abstract available


  159. DING S, Medjahed H, Prevost J, Coutu M, et al
    Lineage-specific differences in the gp120 Inner Domain Layer 3 of Human and Simian Immunodeficiency Viruses.
    J Virol. 2016 Aug 17. pii: JVI.01215.
    PubMed     Text format     Abstract available


  160. SCHMIEDEL D, Tai J, Levi-Schaffer F, Dovrat S, et al
    Human Herpesvirus 6 downregulates the expression of activating ligands during lytic infection to escape elimination by natural killer cells.
    J Virol. 2016 Aug 17. pii: JVI.01164.
    PubMed     Text format     Abstract available


  161. TRINITE B, Chan CN, Lee CS, Levy DN, et al
    Erratum for Trinite et al., HIV-1 Vpr- and Reverse Transcription-Induced Apoptosis in Resting Peripheral Blood CD4 T Cells and Protection by Common Gamma-Chain Cytokines.
    J Virol. 2016;90:7593.
    PubMed     Text format    


  162. MWIMANZI P, Tietjen I, Miller SC, Shahid A, et al
    A novel acylguanidine-based inhibitor of HIV-1.
    J Virol. 2016 Aug 10. pii: JVI.01107.
    PubMed     Text format     Abstract available


  163. VERKERKE HP, Williams JA, Guttman M, Simonich CA, et al
    Epitope-independent purification of native-like envelope trimers from diverse HIV-1 isolates.
    J Virol. 2016 Aug 10. pii: JVI.01351.
    PubMed     Text format     Abstract available


  164. MANGHERA M, Ferguson-Parry J, Lin R, Douville RN, et al
    NF-kappaB and IRF1 Induce Endogenous Retrovirus-K Expression via Interferon-Stimulated Response Elements in its 5' Long Terminal Repeat.
    J Virol. 2016 Aug 10. pii: JVI.01503.
    PubMed     Text format     Abstract available


  165. LIANG Y, Guttman M, Williams JA, Verkerke H, et al
    Changes in structure and antigenicity of HIV-1 Env trimers resulting from removal of a conserved CD4 binding site-proximal glycan.
    J Virol. 2016 Aug 3. pii: JVI.01116.
    PubMed     Text format     Abstract available


    July 2016
  166. LAMERS SL, Rose R, Maidji E, Agsalda-Garcia M, et al
    HIV DNA is frequently present within pathologic tissues evaluated at autopsy from cART-treated patients with undetectable viral load.
    J Virol. 2016 Jul 27. pii: JVI.00674.
    PubMed     Text format     Abstract available


  167. ROSE R, Lamers SL, Nolan DJ, Maidji E, et al
    HIV maintains an evolving and dispersed population among multiple tissues during suppressive cART with periods of rapid expansion corresponding to the onset of cancer.
    J Virol. 2016 Jul 27. pii: JVI.00684.
    PubMed     Text format     Abstract available


  168. MARTRUS G, Niehrs A, Cornelis R, Rechtien A, et al
    Kinetics of HIV-1 latency reversal quantified on the single cell level using a novel flow-based technique.
    J Virol. 2016 Jul 27. pii: JVI.01448.
    PubMed     Text format     Abstract available


  169. DONIUS LR, Cheng Y, Choi J, Sun ZJ, et al
    Generation of long-lived bone marrow plasma cells secreting antibodies specific for HIV-1 gp41 MPER in the absence of polyreactivity.
    J Virol. 2016 Jul 27. pii: JVI.01089.
    PubMed     Text format     Abstract available


  170. HIMES JE, Ho C, Nguyen Q, Amos JD, et al
    Characterization of anatomically compartmentalized plasma and milk simian immunodeficiency virus variants in chronically infected African green monkeys.
    J Virol. 2016 Jul 27. pii: JVI.00701.
    PubMed     Text format     Abstract available


  171. IYER SS, Gangadhara S, Victor B, Shen X, et al
    Virus-like particles displaying trimeric SIV envelope gp160 enhance the breadth of DNA/MVA SIV vaccine induced antibody responses in rhesus macaques.
    J Virol. 2016 Jul 27. pii: JVI.01163.
    PubMed     Text format     Abstract available


  172. RUCEVIC M, Kourjian G, Boucau J, Blatnik R, et al
    MHC-bound HIV Peptides Identified from Various Cell Types Reveal Common Nested Peptides and Novel T Cell Responses.
    J Virol. 2016 Jul 20. pii: JVI.00599.
    PubMed     Text format     Abstract available


  173. YAN Q, Shen C, Qin J, Li W, et al
    HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MiR-942-5p and Activating NF-kappaB Signaling.
    J Virol. 2016 Jul 20. pii: JVI.00797.
    PubMed     Text format     Abstract available


  174. TOWNSLEY S, Mohamed Z, Guo W, McKenna J, et al
    Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization.
    J Virol. 2016 Jul 20. pii: JVI.00853.
    PubMed     Text format     Abstract available


  175. INLORA J, Chukkapalli V, Bedi S, Ono A, et al
    The molecular determinants directing HIV-1 Gag assembly to the virus-containing compartments in primary macrophages.
    J Virol. 2016 Jul 20. pii: JVI.01004.
    PubMed     Text format     Abstract available


  176. JIMENEZ E, Ruiz A, Kloverpris HN, Rodriguez-Plata MT, et al
    Non-human TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells.
    J Virol. 2016 Jul 20. pii: JVI.00819.
    PubMed     Text format     Abstract available


  177. DI SCALA M, Otano I, Gil-Farina I, Vanrell L, et al
    Complementary effects of IL-15 and IFN-alpha induce immunity in HBV transgenic mice.
    J Virol. 2016 Jul 20. pii: JVI.01030.
    PubMed     Text format     Abstract available


  178. GACH JS, Venzon D, Vaccari M, Keele BF, et al
    The relationship between vaccine-induced antibody capture of infectious virus and infection outcomes following low-dose, repeated rectal challenge with SIVmac251.
    J Virol. 2016 Jul 20. pii: JVI.00812.
    PubMed     Text format     Abstract available


  179. LOPKER MJ, Del Prete GQ, Estes JD, Li H, et al
    Derivation and characterization of pathogenic transmitted/founder molecular clones from SIVsmE660 and SIVmac251 following mucosal infection.
    J Virol. 2016 Jul 13. pii: JVI.00718.
    PubMed     Text format     Abstract available


  180. MURGATROYD C, Pirrie L, Tran F, Smith TK, et al
    Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396.
    J Virol. 2016 Jul 6. pii: JVI.01075.
    PubMed     Text format     Abstract available


  181. GRAF T, Fritsch HM, de Medeiros RM, Junqueira DM, et al
    Comprehensive characterization of the HIV-1 molecular epidemiology and demographic history in the Brazilian region most heavily affected by AIDS.
    J Virol. 2016 Jul 6. pii: JVI.00363.
    PubMed     Text format     Abstract available


  182. CHACHAGE M, Pollakis G, Kuffour EO, Haase K, et al
    CD25+FoxP3+ memory CD4 T cells are frequent targets of HIV infection in vivo.
    J Virol. 2016 Jul 6. pii: JVI.00612.
    PubMed     Text format     Abstract available


  183. DING S, Tolbert WD, Prevost J, Pacheco B, et al
    A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability.
    J Virol. 2016 Jul 6. pii: JVI.01068.
    PubMed     Text format     Abstract available


    June 2016
  184. MARTIN JL, Cao S, Maldonado JO, Zhang W, et al
    Distinct particle morphologies revealed through comparative parallel analyses of retrovirus-like particles.
    J Virol. 2016 Jun 29. pii: JVI.00666.
    PubMed     Text format     Abstract available


  185. MURRELL B, Vollbrecht T, Guatelli J, Wertheim JO, et al
    The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.
    J Virol. 2016 Jun 29. pii: JVI.00972.
    PubMed     Text format     Abstract available


  186. ZERBATO JM, Serrao E, Lenzi G, Kim B, et al
    Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells in Vitro.
    J Virol. 2016 Jun 29. pii: JVI.00553.
    PubMed     Text format     Abstract available


  187. DAGENAIS-LUSSIER X, Aounallah M, Mehraj V, El-Far M, et al
    Kynurenine Reduces Memory CD4 T-cell Survival by Interfering with IL-2 Signaling early During HIV-1 Infection.
    J Virol. 2016 Jun 29. pii: JVI.00994.
    PubMed     Text format     Abstract available


  188. CHRISTENSEN-QUICK A, Lafferty M, Sun L, Marchionni L, et al
    Human Th17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection.
    J Virol. 2016 Jun 22. pii: JVI.02869.
    PubMed     Text format     Abstract available


  189. GARDNER MR, Fellinger CH, Prasad NR, Zhou AS, et al
    CD4-induced antibodies promote association of the HIV-1 envelope glycoprotein with CD4-binding site antibodies.
    J Virol. 2016 Jun 22. pii: JVI.00803.
    PubMed     Text format     Abstract available


  190. DUTARTRE H, Claviere M, Journo C, Mahieux R, et al
    Cell-free versus cell-to-cell infection by HIV-1 and HTLV-1: exploring the link among viral source, viral trafficking and viral replication.
    J Virol. 2016 Jun 22. pii: JVI.00407.
    PubMed     Text format     Abstract available


  191. DINAPOLI SR, Hirsch VM, Brenchley JM
    Macrophages in progressive HIV/SIV infections.
    J Virol. 2016 Jun 15. pii: JVI.00672.
    PubMed     Text format     Abstract available


  192. YUAN Z, Kang G, Ma F, Lu W, et al
    Recapitulating Cross-Species Transmission of SIVcpz to Humans Using Humanized-BLT Mice.
    J Virol. 2016 Jun 15. pii: JVI.00860.
    PubMed     Text format     Abstract available


  193. SAITO A, Henning MS, Serrao E, Dubose BN, et al
    The capsid-CPSF6 interaction is dispensable for HIV-1 replication in primary cells but is selected during virus passage in vivo.
    J Virol. 2016 Jun 15. pii: JVI.00019.
    PubMed     Text format     Abstract available


  194. TRAN EE, Nelson EA, Bonagiri P, Simmons JA, et al
    Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry.
    J Virol. 2016 Jun 8. pii: JVI.00406.
    PubMed     Text format     Abstract available


  195. SCHOMMERS P, Martrus G, Matschl U, Sirignano M, et al
    Changes in HIV-1 Capsid stability induced by common CTL-driven viral sequence mutations.
    J Virol. 2016 Jun 8. pii: JVI.00867.
    PubMed     Text format     Abstract available


  196. CALASCIBETTA F, Micci L, Carnathan D, Lawson B, et al
    Antiretroviral therapy in SIV-infected sooty mangabeys: implications for AIDS pathogenesis.
    J Virol. 2016 Jun 8. pii: JVI.00598.
    PubMed     Text format     Abstract available


  197. BULLI L, Apolonia L, Kutzner J, Pollpeter D, et al
    Complex interplay between HIV-1 Capsid and MX2-independent IFNalpha-induced antiviral factors.
    J Virol. 2016 Jun 8. pii: JVI.00458.
    PubMed     Text format     Abstract available


  198. JENSEN K, Nabi R, Van Rompay KK, Robichaux S, et al
    Vaccine-elicited mucosal and systemic antibody responses are associated with reduced simian immunodeficiency viremia in infant rhesus macaques.
    J Virol. 2016 Jun 1. pii: JVI.00481.
    PubMed     Text format     Abstract available


    May 2016
  199. ZHOU S, Bednar MM, Sturdevant CB, Hauser BM, et al
    Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium Between X4 and R5 Viruses In the V1/V2 and V3 Variable Regions.
    J Virol. 2016 May 25. pii: JVI.00441.
    PubMed     Text format     Abstract available


  200. GADHAMSETTY S, Coorens T, de Boer RJ
    Notwithstanding circumstantial alibis, cytotoxic T cells can be major killers of HIV-1 infected cells.
    J Virol. 2016 May 25. pii: JVI.00306.
    PubMed     Text format     Abstract available


  201. ALI A, Kitchen SG, Chen IS, Ng HL, et al
    HIV-1-Specific Chimeric Antigen Receptors Based on Broadly-Neutralizing Antibodies.
    J Virol. 2016 May 25. pii: JVI.00805.
    PubMed     Text format     Abstract available


  202. VERMA A, Rajagopalan P, Lotke R, Varghese R, et al
    Functional incompatibility between the generic NF-kappaB motif and a subtype-specific Sp1III element drives the formation of HIV-1 subtype C viral promoter.
    J Virol. 2016 May 18. pii: JVI.00308.
    PubMed     Text format     Abstract available


  203. GARCIA-MIRANDA P, Becker JT, Benner BE, Blume A, et al
    HIV frameshift site RNA stability correlates with frameshift efficiency and decreased viral infectivity.
    J Virol. 2016 May 18. pii: JVI.00149.
    PubMed     Text format     Abstract available


  204. KOOFHETHILE CK, Ndhlovu ZM, Thobakgale-Tshabalala C, Prado JG, et al
    CD8+ T cell breadth and ex vivo virus inhibition capacity distinguish between viremic controllers with and without protective HLA class I alleles.
    J Virol. 2016 May 18. pii: JVI.00276.
    PubMed     Text format     Abstract available


  205. BAILEY AL, Lauck M, Ghai RR, Nelson CW, et al
    Arteriviruses, pegiviruses, and lentiviruses are common among wild African monkeys.
    J Virol. 2016 May 11. pii: JVI.00573.
    PubMed     Text format     Abstract available


  206. PUJOL FM, Laketa V, Schmidt F, Mukenhirn M, et al
    HIV-1 Vpu Antagonizes CD317/tetherin by Adaptor protein-1-Mediated Exclusion from Virus Assembly Sites.
    J Virol. 2016 May 11. pii: JVI.00504.
    PubMed     Text format     Abstract available


  207. CARTWRIGHT EK, Palesch D, Mavigner M, Paiardini M, et al
    Initiation of antiretroviral therapy restores CD4+ TSCM homeostasis in SIV-infected macaques.
    J Virol. 2016 May 11. pii: JVI.00492.
    PubMed     Text format     Abstract available


  208. GARDINER JC, Mauer EJ, Sherer NM
    HIV-1 Gag, Envelope, and extracellular determinants cooperate to regulate the stability and turnover of virological synapses.
    J Virol. 2016 May 11. pii: JVI.00600.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: